Talk:Skycovione

The vaccine contains only spike protein of the coronavirus
"Skycovion is a self-assembled nanoparticle vaccine targeting the receptor binding domain of the SARS-CoV-2 Spike protein for the parental SARS-Cov-2, jointly developed with the Institute for Protein Design (IPD) at the University of Washington School of Medicine, in combination of GSK’s pandemic adjuvant".

https://www.ema.europa.eu/en/news/ema-starts-review-conditional-marketing-authorisation-application-skycovion-covid-19-vaccine

91.159.191.87 (talk) 18:33, 8 March 2023 (UTC)